SYROS PHARMACEUTICALS, INC. Operating Lease Right-of-Use Assets
SYROS PHARMACEUTICALS, INC. had Operating Lease Right-of-Use Assets of $11.27 million as of 2024-09-30, per its 10-Q filed 2024-10-31.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2024-10-31
- 2024-09-30: Operating Lease, Right-of-Use Asset $11.27M.
- 2024-06-30: Operating Lease, Right-of-Use Asset $11.59M.
- 2024-03-31: Operating Lease, Right-of-Use Asset $11.89M.
- 2023-12-31: Operating Lease, Right-of-Use Asset $12.19M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2024-09-30 | $11.27M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $11.59M 10-Q · filed 2024-07-31 |
| 2024-03-31 | $11.89M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $12.19M 10-Q · filed 2024-10-31 |
| 2023-09-30 | $12.46M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $12.73M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $12.99M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $13.23M 10-K · filed 2024-03-27 |
| 2022-09-30 | $13.46M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $13.69M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $13.90M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $14.10M 10-K · filed 2023-03-02 |
| 2021-09-30 | $14.30M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $14.48M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $14.66M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $14.83M 10-K · filed 2022-03-15 |
| 2020-09-30 | $14.99M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $15.15M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $15.29M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $15.82M 10-K · filed 2021-03-04 |
| 2019-09-30 | $16.50M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $16.83M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $1.31M 10-Q · filed 2019-05-01 |